Results 221 to 230 of about 1,041,807 (313)
The Use of Advance Directives among Patients with Implantable Cardioverter Defibrillators
Tanya H. Tajouri +3 more
semanticscholar +1 more source
Transthyretin cardiomyopathy (ATTR‐CM) frequently coexists with atrial fibrillation, atrial flutter, and atrial tachycardia as well as occasionally ventricular arrhythmias and often conduction abnormalities, necessitating management for arrhythmias. Therefore, for arrhythmia specialists, the ability to diagnose ATTR‐CM and proficiency in arrhythmia ...
Hisanori Kanazawa +12 more
wiley +1 more source
Hitting a new PR: Extravascular ICD implant in a professional powerlifter. [PDF]
Earle W +5 more
europepmc +1 more source
Cardiac digital twins: Modelling the arrhythmic substrate of chemotherapy
The Journal of Physiology, EarlyView.
Radomir Chabiniok, Vlad G. Zaha
wiley +1 more source
Cardiovascular Diseases: From Basic Research to Clinical Application. [PDF]
Bustea C, Tit DM.
europepmc +1 more source
Adolescents with Implantable Cardioverter Defibrillators: A Patient and Parent Perspective
Belinda Rahman +5 more
semanticscholar +1 more source
Supraventricular Tachycardia Ablation in the Elderly—Characteristics and Outcomes
This single‐center retrospective study found that supraventricular tachycardia (SVT) ablation is safe and effective in younger and elderly patients. It should be considered for all symptomatic individuals regardless of age. However, the type of SVT and the presence of comorbidities, including frailty, should be considered in the clinical decision ...
Yi Yi Chua +8 more
wiley +1 more source
This nationwide analysis of 3573 transvenous lead extraction (TLE) procedures from 108 certified hospitals demonstrated a steady rise in TLEs, driven by increasing non‐infectious indications. Also, TLE use varied across regions, indicating persistent geographic disparities. ABSTRACT Background The increasing use of cardiovascular implantable electronic
Toshihiro Nakamura +6 more
wiley +1 more source
Indications, prognosis, and complications of de Novo implantable cardioverter defibrillators in patients with and without type 2 diabetes: a nationwide registry-based cohort study. [PDF]
Zhou Y +7 more
europepmc +1 more source

